MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis
USA - NASDAQ:MHUA - KYG5966G1082 - Common Stock
0.4839 USD
+0.06 (+13.86%)
0.45 USD
-0.03 (-7.01%)
Taking everything into account, MHUA scores 5 out of 10 in our fundamental rating. MHUA was compared to 191 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA is valued correctly, but it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MHUA had positive earnings in the past year.
MHUA had a positive operating cash flow in the past year.
MHUA had positive earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: MHUA reported negative operating cash flow in multiple years.
1.2 Ratios
MHUA has a Return On Assets of 8.35%. This is amongst the best in the industry. MHUA outperforms 92.15% of its industry peers.
The Return On Equity of MHUA (9.79%) is better than 84.82% of its industry peers.
MHUA has a better Return On Invested Capital (9.47%) than 89.53% of its industry peers.
MHUA had an Average Return On Invested Capital over the past 3 years of 6.66%. This is in line with the industry average of 8.46%.
The last Return On Invested Capital (9.47%) for MHUA is above the 3 year average (6.66%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 9.79% | ||
| ROIC | 9.47% |
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
1.3 Margins
MHUA's Profit Margin of 10.94% is amongst the best of the industry. MHUA outperforms 83.77% of its industry peers.
MHUA's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 14.20%, MHUA belongs to the best of the industry, outperforming 82.72% of the companies in the same industry.
In the last couple of years the Operating Margin of MHUA has declined.
MHUA has a worse Gross Margin (34.08%) than 73.30% of its industry peers.
In the last couple of years the Gross Margin of MHUA has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.2% | ||
| PM (TTM) | 10.94% | ||
| GM | 34.08% |
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
2. Health
2.1 Basic Checks
MHUA has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
MHUA has more shares outstanding than it did 1 year ago.
MHUA has more shares outstanding than it did 5 years ago.
MHUA has about the same debt/assets ratio as last year.
2.2 Solvency
MHUA has an Altman-Z score of 3.12. This indicates that MHUA is financially healthy and has little risk of bankruptcy at the moment.
MHUA has a Altman-Z score of 3.12. This is in the better half of the industry: MHUA outperforms 70.16% of its industry peers.
The Debt to FCF ratio of MHUA is 0.55, which is an excellent value as it means it would take MHUA, only 0.55 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.55, MHUA belongs to the top of the industry, outperforming 93.19% of the companies in the same industry.
MHUA has a Debt/Equity ratio of 0.05. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of MHUA (0.05) is better than 66.49% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.55 | ||
| Altman-Z | 3.12 |
ROIC/WACC1.61
WACC5.88%
2.3 Liquidity
MHUA has a Current Ratio of 5.26. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of MHUA (5.26) is better than 78.01% of its industry peers.
MHUA has a Quick Ratio of 5.21. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA has a better Quick ratio (5.21) than 82.72% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.26 | ||
| Quick Ratio | 5.21 |
3. Growth
3.1 Past
The earnings per share for MHUA have decreased strongly by -29.57% in the last year.
The earnings per share for MHUA have been decreasing by -13.75% on average. This is quite bad
Looking at the last year, MHUA shows a decrease in Revenue. The Revenue has decreased by -2.09% in the last year.
Measured over the past years, MHUA shows a small growth in Revenue. The Revenue has been growing by 4.01% on average per year.
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 0.88, the valuation of MHUA can be described as very cheap.
Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 99.48% of the companies are valued more expensively.
MHUA's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.88 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Price/Free Cash Flow ratio, MHUA is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.06 | ||
| EV/EBITDA | -0.03 |
4.3 Compensation for Growth
The decent profitability rating of MHUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
MHUA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.4839
+0.06 (+13.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.06%
Inst Owner Change-51.54%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap15.44M
AnalystsN/A
Price TargetN/A
Short Float %0.14%
Short Ratio0.19
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 0.88 | ||
| Fwd PE | N/A | ||
| P/S | 0.11 | ||
| P/FCF | 1.06 | ||
| P/OCF | 1.05 | ||
| P/B | 0.1 | ||
| P/tB | 0.1 | ||
| EV/EBITDA | -0.03 |
EPS(TTM)0.55
EY113.66%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.45
FCFY93.96%
OCF(TTM)0.46
OCFY94.82%
SpS4.46
BVpS4.98
TBVpS4.97
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.35% | ||
| ROE | 9.79% | ||
| ROCE | 12.71% | ||
| ROIC | 9.47% | ||
| ROICexc | 10.48% | ||
| ROICexgc | 10.51% | ||
| OM | 14.2% | ||
| PM (TTM) | 10.94% | ||
| GM | 34.08% | ||
| FCFM | 10.2% |
ROA(3y)5.46%
ROA(5y)9.91%
ROE(3y)6.42%
ROE(5y)12.22%
ROIC(3y)6.66%
ROIC(5y)11.82%
ROICexc(3y)7.64%
ROICexc(5y)13.07%
ROICexgc(3y)7.74%
ROICexgc(5y)13.18%
ROCE(3y)8.91%
ROCE(5y)15.78%
ROICexcg growth 3Y-27.75%
ROICexcg growth 5Y-25.86%
ROICexc growth 3Y-27.69%
ROICexc growth 5Y-25.71%
OM growth 3Y-16.41%
OM growth 5Y-9.53%
PM growth 3Y-17.73%
PM growth 5Y-10.37%
GM growth 3Y-3.53%
GM growth 5Y-3.21%
F-Score4
Asset Turnover0.76
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.05 | ||
| Debt/FCF | 0.55 | ||
| Debt/EBITDA | 0.38 | ||
| Cap/Depr | 23.4% | ||
| Cap/Sales | 0.09% | ||
| Interest Coverage | 81.6 | ||
| Cash Conversion | 70.45% | ||
| Profit Quality | 93.21% | ||
| Current Ratio | 5.26 | ||
| Quick Ratio | 5.21 | ||
| Altman-Z | 3.12 |
F-Score4
WACC5.88%
ROIC/WACC1.61
Cap/Depr(3y)500.19%
Cap/Depr(5y)470.87%
Cap/Sales(3y)2.53%
Cap/Sales(5y)2.53%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.57%
EPS 3Y-27.74%
EPS 5Y-13.75%
EPS Q2Q%-18.41%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-2.09%
Revenue growth 3Y-2.33%
Revenue growth 5Y4.01%
Sales Q2Q%-0.19%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.01%
EBIT growth 3Y-18.36%
EBIT growth 5Y-5.9%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y701.6%
FCF growth 3YN/A
FCF growth 5Y109.43%
OCF growth 1Y543.15%
OCF growth 3YN/A
OCF growth 5Y9.47%